• ryedaft@sh.itjust.works
    link
    fedilink
    English
    arrow-up
    5
    ·
    19 hours ago

    Costs aren’t just research and purification, it’s also good manufacturing practice and quality control.

    • fullsquare@awful.systems
      link
      fedilink
      English
      arrow-up
      4
      ·
      edit-2
      15 hours ago

      i mean i don’t think about it as a separate budget line because if you don’t have that you get police raids and investigation instead of normal business, but yea. insulin is purified using HPLC, so at all times you get some of analytical data about fractions you just made, so some of QC, not all, but already something, already happens at this point

      my point is that actual manufacturing costs will be low because biotech scalability logic is that you need to make yeast or something that makes peptide you like and then all you need to do is keep bioreactor alive and happy. lots of what is left is in purification

      also it’s an injectable so it’s gonna be kept to some standards that non-injected drugs aren’t. whoever comes up with insulin pill will be printing money